Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04460872 · ClinicalTrials.gov registry record · Phase 2
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
A Phase 2 study of Spinal Cord Injuries and Spinal Cord Injury, sponsored by North Florida Foundation for Research and Education.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
- 2
- Study locations
NCT04460872: Recruiting Phase 2 study of Spinal Cord Injuries and Spinal Cord Injury, sponsored by North Florida Foundation for Research and Education.
NCT04460872 is a Phase 2 study of Spinal Cord Injuries and Spinal Cord Injury that is actively recruiting participants, run by North Florida Foundation for Research and Education. The registered enrollment target is 21 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04460872, a Phase 2 study of Spinal Cord Injuries and Spinal Cord Injury, is actively recruiting participants, sponsored by North Florida Foundation for Research and Education.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot study will determine the feasibility of implementing a combinatory rehabilitation strategy involving testosterone replacement therapy (TRT) with locomotor training (LT; walking on a treadmill with assistance and overground walking) in men with testosterone deficiency and walking dysfunction after incomplete or complete spinal cord injury. The investigators hypothesize that LT+TRT treatment will improve muscle size and bone mineral density in men with low T and ambulatory dysfunction after incomplete or complete SCI, along with muscle fundtion and walking recovery in men with T low and ambulatory dysfunction ater incomplete SCI.
Primary Outcome
change in thigh muscle cross-sectional area assessed via MRI
Conditions Studied
Interventions
- DRUG Testosterone Enanthate
- BEHAVIORAL Locomotor Training
Study Locations (2)
Florida
- North Florida/South Georgia Veterans Health System - Gainesville
- Brooks Rehabilitation - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-01-31 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 2 |
What NCT04460872 shows while recruiting
NCT04460872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (66% lower).
The record links to 10 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Testosterone Enanthate is the first listed.
NCT04460872 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04460872 about?
NCT04460872 is a clinical study titled "Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury". This pilot study will determine the feasibility of implementing a combinatory rehabilitation strategy involving testosterone replacement therapy (TRT) with locomotor training (LT; walking on a treadmill with assistance and overground walking) in men with testosterone deficiency and walking dysfuncti...
What is the current status of trial NCT04460872?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2021-01-31. Estimated completion is 2026-06-30.
What conditions does trial NCT04460872 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury, Hypogonadism, Central Nervous System Diseases, Endocrine System Diseases.
What interventions are being tested in trial NCT04460872?
The interventions under investigation include: Testosterone Enanthate (DRUG), Locomotor Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04460872?
This trial is sponsored by North Florida Foundation for Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04460872 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04460872's enrollment target sits among peer trials
21 123rd of 202 higher than 78 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Epidural Stimulation and Resistance Training After SCI
RECRUITING · Phase 2
-
Intravesical LGG VS Saline Bladder Wash RCT
RECRUITING · Phase 2
-
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
RECRUITING · Phase 2
-
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
RECRUITING · Phase 2
-
Effects of 5HTP on the Injured Human Spinal Cord
RECRUITING · Phase 2
-
Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy